← Back
$ONC All transactions

BeOne Medicines Ltd.

A

$ Value

$0

Shares

348,374

Price

$0

Filed

Jun 12

Insider

Name

OYLER JOHN

Title

Chief Executive Officer

CIK

0001042047

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-10

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

348,374

Footnotes

Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon a change of control or certain termination events. | These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership. | These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. | These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. | These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account. | These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership. | The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. | These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon a change of control or certain termination events.

Filing Info

Accession No.

0001651308-25-000104

Form Type

4

Issuer CIK

0001651308

OYLER JOHN's History

Date Ticker Type Value
2026-03-06 ONC A $0
2026-03-06 ONC A $0
2025-12-16 ONC $565K
2025-12-16 ONC $181K
2025-12-16 ONC $775K
2025-12-16 ONC $457K
2025-12-16 ONC $2.3M
2025-12-16 ONC $495K
2025-12-16 ONC $1.7M
2025-12-16 ONC $382K

Other Insiders at ONC (90d)

Insider Bought Sold Last
OYLER JOHN
Chief Executive Officer
2026-03-06
Wu Xiaobin
President and COO
2026-03-06
Wang Lai
President, Global Head of R&D
2026-03-06
Lee Chan Henry
SVP, General Counsel
$786K 2026-04-08
Rosenberg Aaron
Chief Financial Officer
2026-03-06